Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Apr
24
2020
Additional $480 Billion in Coronavirus Relief Package Approved Including $310 Billion for Payroll Protection Program and $75 Billion for Health Care Providers Treating COVID-19 Cases Norris McLaughlin P.A.
May
13
2021
Restaurant Revitalization Fund: Economic Relief for Restaurants Norris McLaughlin P.A.
Jun
30
2023
Sean “Diddy” Combs Sues Diageo, Alleging Neglect of His Drink Brands: What Celebrities and Influencers Can Learn from This Norris McLaughlin P.A.
Mar
16
2020
Coronavirus (COVID-19) Update for Pennsylvania Food and Beverage Businesses Norris McLaughlin P.A.
Mar
20
2020
The Updated Rules on Joint Employment: A More Direct Approach and With Less Worry for Pharmaceutical Companies Norris McLaughlin P.A.
Sep
25
2023
Bonding Requirements Complicate TTB Permit Filing Norris McLaughlin P.A.
Apr
24
2020
Investors: SEC Warns to Be Aware of Uptick of Fraud in the Cannabis Industry Norris McLaughlin P.A.
May
21
2020
Governor Wolf Signs Bill to Allow Mixed Drinks To-Go for Restaurant and Hotel Licensees Norris McLaughlin P.A.
Jan
11
2024
Hopping Towards Change: New Jersey Proposes A Crafty New Solution to the Special Ruling Norris McLaughlin P.A.
Jul
16
2020
“I Thought Groundhog Day Was in February?” Pennsylvania Governor Rewinds Clock Restricting the Operations of Bars and Restaurants to Mitigate the Spread of the Coronavirus Norris McLaughlin P.A.
May
14
2021
Will There Be a Craft Marijuana Industry in New Jersey? Norris McLaughlin P.A.
Aug
20
2021
SEYIDOGLU: Even “Incontestable” Trademark Registrations Are Vulnerable to Cancellation Norris McLaughlin P.A.
Nov
19
2021
A Dispute Is Bubbling Over for the Prosecco Name Norris McLaughlin P.A.
Jun
10
2022
Ninth Circuit Extends Trademark Protection to Delta-8 THC Goods Norris McLaughlin P.A.
Aug
3
2022
How Immigration Could Affect Your Grocery Bill Norris McLaughlin P.A.
Jan
13
2023
Higher Prices in Pennsylvania and Liquor Law Reform in New Jersey Norris McLaughlin P.A.
Jan
7
2020
Pennsylvania Liquor Control Board Tackles Wine Slushie Sales by Restaurant Licensees Norris McLaughlin P.A.
Jul
14
2023
FTC and FDA Issue Warnings for THC Edibles in Kids Candy Packaging Norris McLaughlin P.A.
Mar
19
2020
Coronavirus (COVID-19) Temporary Advisory Notice: Breaking Down the Latest Guidance From the Pennsylvania Liquor Control Board Norris McLaughlin P.A.
Mar
24
2020
COVID-19 and the New Jersey Alcoholic Beverage Industry Norris McLaughlin P.A.
Apr
1
2020
TTB Steps Up Amid Crisis - Postpones Excise Tax Filing and Payment Dates Norris McLaughlin P.A.
Apr
20
2020
DHS Temporarily Amends Certain H-2A Visa Requirements During COVID-19 National Emergency Norris McLaughlin P.A.
May
28
2020
Pennsylvania to Permit Outdoor Dining on June 5 in Yellow Phase Counties and Issues Guidance for Dine-In Service for Green Phase Counties on May 29 Norris McLaughlin P.A.
Mar
25
2024
The Price Is “Wrong”: SEC Sanctions Pharma Company for Faulty Rebates Norris McLaughlin P.A.
Nov
5
2021
Plant-Based Food Labeling Legislative Update Norris McLaughlin P.A.
Dec
16
2014
USPTO Issues New Subject Matter Eligibility Examination Interim Guidelines – Nature-Based Product Guidance Sterne, Kessler, Goldstein & Fox P.L.L.C.
Mar
23
2015
One More Hurdle Cleared – Amgen’s Preliminary Injunction Motion for Filgrastim is Denied Sterne, Kessler, Goldstein & Fox P.L.L.C.
Aug
15
2017
Patent Term Extension Considerations for BioPharma Patents Sterne, Kessler, Goldstein & Fox P.L.L.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins